Clinical Trial Update: T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the combination of T-DM1 (ado-trastuzumab emtansine) and palbociclib in metastatic HER2-positive breast cancer; results are poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)
• T-DM1 (ado-trastuzumab emtansine) (ado-trastuzumab emtansine)

Snippet

Sponsor: University of Arizona | Conditions: HER2-positive Breast Cancer, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-07-24